This group was comprised of 3 PFGE subtypes labeled B1 (n = 123, CDN type 142), B2 (n = 1, CDN type 378), and B3 (n = 2, CDN type 418).
We used three pneumococcal isolates (serotype, MIC of CDN): Strain 1 (6B, 1 µg/ml), Strain 2 (19F, 2 µg/ml) and Strain 3 (23F, 4 µg/ml).
In-vivo dose-ranging experiments with HS (dilutions 1/2 1/16) and CDN (6.25 mg/kg–100 mg/kg tid for 48 h) were performed to determine the minimal protective dilution/dose (highest survival) and the non-protective highest dilution/dose (highest mortality: HS-np dilution and CDN-np dose) over 7 days.
A computerized two-compartment pharmacodynamic model was used to explore β-lactam effects on the evolution over time of a bacterial load containing common pharyngeal isolates by simulating free serum concentrations obtained with amoxicillin (AMX) 875 mg tid, amoxicillin/clavulanic acid (AMC) 875/125 mg tid and cefditoren (CDN) 400 mg bid regimens over 24 h.
Also, the probability of change is given as ρ 0. Based on the results mentioned above, for the concerned discrete-time CDNs (1), the coupling strength with the binomial random variable can be represented in the model of discrete-time CDNs with randomly changing coupling strength (6).
Please note that the costs are substantially higher for more severe stroke patients: costs for patients with Modified Rankin Score 4 = 100,000$CDN and score 5 = 200,000$CDN.
Hybrid CDN-P2P networks blend Content Delivery Networks (CDN) and Peer-to-Peer (P2P) networks to overcome their shortcomings.
In this work, we introduce a novel replication strategy which enables traditional CDNs to offer Hybrid CDN-P2P streaming content delivery services.
A reported case describes a malicious customer creating forwarding loops inside one Content Delivery Network(CDN) or across multiple CDNs [17].
In particular, processing and communication complexities of the proposed solution are studied and its performance is analyzed in a typical Hybrid CDN-P2P network in comparison to related strategies.
This work was supported by an unrestricted grant from Pfizer Canada (FCA-CDN-98-001).
